Definium Therapeutics DFTX
NASDAQ DFTX
$36.00 +0.51 (+1.44%)
At close: Oct 22, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Amortization of Deferred Charges (2026)

Updated

Analysis

Definium Therapeutics (DFTX) Amortization of Deferred Charges (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Definium Therapeutics 3.98 Bn 1.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42,000.00
Mar 31, 2026 40,000.00
API Access

Definium Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=DFTX&period=max&api_key=YOUR_API_KEY